Clotting Epidemic, Cancer, Heart Disease
In this video, James Privitera spends about 28 minutes speaking on "Clotting Epidemic, Cancer, Heart Disease" at the 33rd Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About James Privitera
JAMES PRIVITERA, M.D. graduated in 1962 with a B.S. Degree in Biology and Chemistry from Canisius College, Buffalo, New York. Later he took Biochemistry at University of Buffalo Graduate School. He gained research experience at Roswell Park Memorial Institute, Buffalo, New York, but decided to go into medicine. In 1967, he graduated with his M.D. Degree from Creighton University School of Medicine, Omaha, Nebraska, followed by a one year Internal Medicine Internship at Providence Hospital, Seattle, Washington. For the next year he took an Internal Medicine Residency at Presbyterian Hospital, San Francisco, California. From 1969-1970 Dr. Privitera took a Clinical Fellowship in Allergy, Immunology and Rheumatology at Scripps Clinic and Research Foundation, La Jolla, California. From 1970 on he entered a private practice of Allergy and Nutrition and practices in Covina, California. Dr. Privitera has done original scientific research with the dark field microscope, analyzing and identifying 25 factors with various disease conditions and nutritionally deficient states. He has co-authored a book on the subject with Alan Stang, Silent Clots, Life's Biggest Killers.It deals with Lockstep Medicine's Conspiracy to suppress the test that should be done in emergency rooms throughout the world. He may be contacted by calling (626) 966-1618.
Transcription
Thank you very much. It's nice to be back. I was here a few years ago and I'm going to be talking about Clot's and this and an epidemic that's going on. Why do I say epidemic? Well, because of one of my doctor friends. He said, well, I know you're seeing a lot of clotting, but do you know how much you've seen? And I said, I really don't know. I said, that's I know it's a lot. And so Dr. John Martin, who's out in the audience now, he said, well, what did you take? 100 people, random people and see how many of those people are clotting? Well, it turned out that it's one out of three people are seriously clotting. Seriously clotting is. Meaning four times the size were red cell. Well, why do I think that's serious? Because we also did a test called a highly sensitive C reactive protein on 22 patients. And we found greater than a 95 percent correlation. That's a heart risk. It's also a cancer risk, but it's an inflammation risk. So you're going to hear me say many times that you're going to hear see books and you're going to hear this word used a lot inflammation. So here's the way you should interpret that word. Inflammation means clotting, which means hyper coagulate ability. So that's enough of a mouthful. OK. So this is how do we determine this or we do this dark field test. We've all seen me use these slides before. That's a normal and here's some red cells that stick together. By the way, the red cell sticking together is a rare phenomenon occurs in multiple myeloma, but it's not generally seen if a small drop is used on a slide and in the proper techniques used. It's rare for us to see that. So I hope you don't go to somebody who finds this all the time because it's not common. Same here. And this is just to point out that if your red cells are sticking together and you're real ill, that if somebody took your blood, the hemoglobin will be down. But ness wouldn't necessarily mean you had low red cells. It would mean that the red cells all were piling it on the bottom of the vessel. So things like heparin or hydrochloric acid or niacin would help separate that hep separate separate the red cells. The flow of the of the cells is free and that's the way it should be. This is a neutrophil. It has to do with defense. This is a neutrophil with five lobes getting a little bit too common. It means folic acid deficiency. And